[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

EPIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.70%

Insider Buying (Last 12 Months): $154,486.97

Insider Selling (Last 12 Months): $12,114,699.12

ESSA Pharma Insider Trading History Chart

ESSA Pharma Share Price & Price History

^$1.73

▼ -0.01 (-0.57%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

The Crypto That’s Making Wall Street Sweat

From Crypto 101 Media | Ad

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

ESSA Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2024	Growth N. V. Biotech	major shareholder	Sell	7,879,583	$1.53	$12,055,761.99
10/7/2024	Peter Virsik	COO	Sell	694	$6.03	$4,184.82	7,776
9/9/2024	Peter Virsik	COO	Sell	694	$6.00	$4,164.00	8,470
9/3/2024	Peter Virsik	COO	Sell	2,082	$6.03	$12,554.46	9,164
5/6/2024	Peter Virsik	COO	Sell	694	$6.95	$4,823.30	11,246
4/5/2024	Peter Virsik	COO	Sell	694	$7.94	$5,510.36	11,940
3/5/2024	Peter Virsik	COO	Sell	694	$8.98	$6,232.12	12,634
1/16/2024	Peter Virsik	COO	Sell	1,718	$10.01	$17,197.18	14,022
1/5/2024	Peter Virsik	COO	Sell	699	$6.11	$4,270.89	14,022
12/14/2023	David Ross Parkinson	CEO	Buy	9,223	$2.30	$21,212.90	65,675
11/21/2023	Franklin M Berger	Director	Buy	23,259	$5.73	$133,274.07	784,404
11/2/2023	Franklin M Berger	Director	Buy	60,000	$5.35	$321,000.00	744,404
10/26/2022	Growth N V Biotech	Major Shareholder	Buy	1,500,000	$3.98	$5,970,000.00	7,379,583
7/18/2022	Growth N V Biotech	Major Shareholder	Buy	300,000	$3.16	$948,000.00	5,879,583
7/14/2022	Growth N V Biotech	Major Shareholder	Buy	347,204	$2.79	$968,699.16	5,337,918
6/30/2022	David Ross Parkinson	CEO	Buy	4,887	$2.96	$14,465.52	32,108
4/27/2022	Growth N V Biotech	Major Shareholder	Sell	25,100	$5.85	$146,835.00	4,990,714

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for ESSA Pharma (NASDAQ:EPIX)

75.12% of ESSA Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ESSA Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2024	RTW Investments LP	3,261,496	$19.77M	0.3%	+41.9%	7.351%
11/15/2024	Parkman Healthcare Partners LLC	345,902	$2.10M	0.3%	+37.2%	0.780%
11/14/2024	Bellevue Group AG	7,879,583	$47.75M	0.8%	-0.1%	17.759%
11/14/2024	PFM Health Sciences LP	2,742,936	$16.62M	0.9%	-7.5%	6.182%
5/16/2024	Janus Henderson Group PLC	1,175,242	$9.98M	0.0%	+7.9%	2.657%
5/15/2024	Bellevue Group AG	7,889,583	$66.98M	1.0%	-0.1%	17.834%
5/14/2024	EntryPoint Capital LLC	4,420	$38K	0.0%	N/A	0.010%
5/1/2024	BNP Paribas Financial Markets	42,495	$0.36M	0.0%	-26.1%	0.096%
2/15/2024	PFM Health Sciences LP	3,262,500	$21.53M	1.3%	-22.3%	7.388%
2/14/2024	RTW Investments LP	2,298,662	$15.17M	0.2%	N/A	5.205%
2/7/2024	BNP Paribas Financial Markets	57,466	$0.38M	0.0%	+164.9%	0.130%
11/15/2023	Rock Springs Capital Management LP	677,005	$2.09M	0.1%	+2.1%	1.535%
11/9/2023	Group One Trading L.P.	41,860	$0.13M	0.0%	-14.2%	0.095%
11/9/2023	Rhenman & Partners Asset Management AB	234,000	$0.72M	0.1%	-34.4%	0.531%
8/14/2023	Rock Springs Capital Management LP	663,317	$1.79M	0.0%	+26.4%	1.504%
8/14/2023	Driehaus Capital Management LLC	28,300	$76K	0.0%	-89.3%	0.064%
8/11/2023	Cibc World Market Inc.	160,643	$0.43M	0.0%	-23.1%	0.364%
7/26/2023	Privium Fund Management B.V.	20,032	$55K	0.0%	N/A	0.045%
5/16/2023	Ally Bridge Group NY LLC	236,583	$0.70M	0.9%	-70.8%	0.537%
5/12/2023	Rhenman & Partners Asset Management AB	356,500	$1.05M	0.1%	-4.9%	0.809%
5/3/2023	Privium Fund Management UK Ltd	20,032	$61K	0.0%	N/A	0.045%
2/15/2023	Avidity Partners Management LP	1,855,400	$4.68M	0.1%	-24.6%	4.208%
2/14/2023	Driehaus Capital Management LLC	264,571	$0.67M	0.0%	N/A	0.600%
2/3/2023	Frazier Life Sciences Management L.P.	605,141	$1.53M	0.1%	-12.7%	1.373%
11/15/2022	PFM Health Sciences LP	1,478,252	$2.69M	0.1%	+53.7%	3.354%
11/15/2022	Eventide Asset Management LLC	1,561,251	$2.84M	0.1%	-53.6%	3.543%
11/15/2022	BVF Inc. IL	8,748,629	$15.92M	0.7%	+136.5%	19.852%
11/15/2022	Bellevue Group AG	5,898,583	$10.74M	0.2%	+17.7%	13.385%
11/15/2022	Bioimpact Capital LLC	405,700	$0.74M	0.2%	-38.6%	0.921%
11/14/2022	RTW Investments LP	1,311,294	$2.39M	0.1%	-50.3%	2.975%
11/10/2022	AlpInvest Partners B.V.	39,930	$73K	0.0%	-62.5%	0.091%
8/12/2022	Ensign Peak Advisors Inc	26,282	$83K	0.0%	-70.6%	0.060%
8/11/2022	Trexquant Investment LP	19,147	$60K	0.0%	+24.3%	0.043%
8/11/2022	Alps Advisors Inc.	26,140	$82K	0.0%	N/A	0.059%
8/10/2022	Cibc World Market Inc.	94,578	$0.30M	0.0%	-17.9%	0.215%
8/8/2022	Walleye Capital LLC	104,393	$0.33M	0.0%	+75.8%	0.237%
8/3/2022	Candriam S.C.A.	567,343	$1.79M	0.0%	-3.5%	1.289%
5/17/2022	Eventide Asset Management LLC	4,170,259	$25.77M	0.4%	+25.7%	9.474%
5/16/2022	Blackstone Inc.	2,003,103	$12.38M	0.0%	-39.4%	4.551%
5/16/2022	Frazier Life Sciences Management L.P.	692,910	$4.28M	0.4%	N/A	1.574%
5/9/2022	Qube Research & Technologies Ltd	47,655	$0.30M	0.0%	N/A	0.108%
5/4/2022	Prospera Financial Services Inc	7,568	$47K	0.0%	N/A	0.017%
5/2/2022	Cannon Global Investment Management LLC	15,300	$95K	0.1%	N/A	0.035%
4/27/2022	Alta Wealth Advisors LLC	11,285	$70K	0.0%	N/A	0.026%
3/10/2022	Values First Advisors Inc.	13,668	$0.19M	0.1%	N/A	0.031%
2/19/2022	Woodline Partners LP	684,247	$9.72M	0.1%	+286.6%	1.556%
2/15/2022	CIBC World Markets Inc.	84,230	$1.20M	0.0%	N/A	0.192%
2/14/2022	Virtus ETF Advisers LLC	13,643	$0.19M	0.1%	+74.3%	0.031%
2/14/2022	Altium Capital Management LP	345,000	$4.90M	1.4%	N/A	0.784%
2/14/2022	Boxer Capital LLC	724,500	$10.29M	0.4%	+5.5%	1.647%
2/14/2022	Soleus Capital Management L.P.	3,525,457	$50.06M	5.0%	+22.9%	8.015%
2/14/2022	Eventide Asset Management LLC	3,318,647	$47.13M	0.6%	+52.2%	7.545%
2/11/2022	Ensign Peak Advisors Inc	89,448	$1.27M	0.0%	+7.7%	0.203%
2/11/2022	Bioimpact Capital LLC	668,688	$9.50M	1.7%	-2.1%	1.520%
2/10/2022	Candriam Luxembourg S.C.A.	626,276	$8.89M	0.1%	+108.4%	1.424%
2/8/2022	Frazier Management LLC	543,470	$7.72M	0.6%	+51.7%	1.236%
2/8/2022	Swiss National Bank	53,200	$0.76M	0.0%	+8.4%	0.121%
2/3/2022	Advisor Group Holdings Inc.	4,559	$65K	0.0%	-28.8%	0.010%
12/17/2021	Jefferies Group LLC	62,502	$0.50M	0.0%	N/A	0.142%
11/16/2021	Schonfeld Strategic Advisors LLC	10,600	$85K	0.0%	-87.8%	0.024%
11/16/2021	Janus Henderson Group PLC	3,477,844	$27.84M	0.0%	+72.4%	7.907%
11/16/2021	Two Sigma Advisers LP	564,800	$4.52M	0.0%	+1,319.1%	1.284%
11/16/2021	Two Sigma Investments LP	502,406	$4.02M	0.0%	+1,658.9%	1.142%
11/16/2021	BVF Inc. IL	2,851,461	$22.81M	0.9%	+16.3%	6.483%
11/16/2021	BioImpact Capital LLC	683,287	$5.47M	0.8%	N/A	1.553%
11/16/2021	Citadel Advisors LLC	685,531	$5.49M	0.0%	-4.9%	1.559%
11/15/2021	RTW Investments LP	2,637,192	$21.10M	0.3%	-13.6%	5.996%
11/15/2021	Rock Springs Capital Management LP	508,044	$4.06M	0.1%	+1.0%	1.155%
11/15/2021	Sphera Funds Management LTD.	469,402	$3.76M	0.3%	-27.6%	1.067%
11/15/2021	HighVista Strategies LLC	143,566	$1.15M	0.8%	+497.5%	0.326%
11/15/2021	Ensign Peak Advisors Inc	83,068	$0.67M	0.0%	-53.4%	0.189%
11/12/2021	Renaissance Technologies LLC	141,500	$1.13M	0.0%	+618.3%	0.322%
11/12/2021	Macquarie Group Ltd.	6,106	$49K	0.0%	N/A	0.014%
11/12/2021	Credit Suisse AG	13,713	$0.11M	0.0%	+12.2%	0.031%
11/12/2021	Oppenheimer & Co. Inc.	47,300	$0.38M	0.0%	N/A	0.108%
11/12/2021	Bellevue Group AG	5,034,814	$40.28M	0.4%	+104.7%	11.447%
11/12/2021	Rhenman & Partners Asset Management AB	600,000	$4.80M	0.3%	+130.8%	1.364%
11/10/2021	Goldman Sachs Group Inc.	121,601	$0.97M	0.0%	+82.1%	0.276%
11/10/2021	Alliancebernstein L.P.	49,231	$0.39M	0.0%	+212.7%	0.112%
11/9/2021	Barclays PLC	77,300	$0.62M	0.0%	N/A	0.176%
11/9/2021	BlackRock Inc.	81,638	$0.65M	0.0%	+23.0%	0.186%
11/8/2021	Swiss National Bank	49,100	$0.39M	0.0%	+4.2%	0.112%
11/5/2021	Advisor Group Holdings Inc.	6,401	$51K	0.0%	-72.4%	0.015%
11/4/2021	Deutsche Bank AG	43,701	$0.35M	0.0%	+2,696.0%	0.099%
8/25/2021	Marshall Wace LLP	14,479	$0.41M	0.0%	N/A	0.036%
8/25/2021	Marshall Wace North America L.P.	273,413	$7.81M	0.0%	+50.2%	0.676%
8/17/2021	Sphera Funds Management LTD.	648,303	$18.52M	1.3%	+38.2%	1.602%
8/17/2021	Price T Rowe Associates Inc. MD	24,303	$0.69M	0.0%	N/A	0.060%
8/17/2021	Acuta Capital Partners LLC	232,896	$6.65M	2.7%	-18.9%	0.576%
8/17/2021	BVF Inc. IL	2,451,561	$70.04M	2.6%	-15.7%	6.060%
8/17/2021	Citadel Advisors LLC	720,701	$20.59M	0.0%	+48.1%	1.781%
8/16/2021	Blackstone Inc	3,303,103	$94.37M	0.2%	-7.6%	8.165%
8/16/2021	Commodore Capital LP	281,911	$8.05M	2.8%	+59.4%	0.697%
8/16/2021	Morgan Stanley	496,809	$14.19M	0.0%	-13.3%	1.228%
8/16/2021	Credit Suisse AG	12,226	$0.35M	0.0%	N/A	0.030%
8/16/2021	Schonfeld Strategic Advisors LLC	87,056	$2.49M	0.0%	-14.8%	0.215%
8/16/2021	Maven Securities LTD	17,711	$0.51M	0.0%	-36.9%	0.044%
8/16/2021	Omega Fund Management LLC	328,196	$9.38M	1.6%	-2.6%	0.811%
8/16/2021	Goldman Sachs Group Inc.	66,774	$1.91M	0.0%	+62.9%	0.165%
8/16/2021	Marshall Wace LLP	14,479	$0.41M	0.0%	N/A	0.036%

Data available starting January 2016

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Today's Range

Now: $1.73

$1.69

$1.78

50 Day Range

MA: $4.95

$1.40

$7.10

52 Week Range

Now: $1.73

$1.40

$11.67

Volume

196,493 shs

Average Volume

297,261 shs

Market Capitalization

$76.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.84

Who are the company insiders with the largest holdings of ESSA Pharma?: ESSA Pharma's top insider investors include:
Franklin M Berger (Director)
David Ross Parkinson (CEO)
Peter Virsik (COO)
Growth N V Biotech (Major Shareholder)
Learn More about top insider investors at ESSA Pharma.
Who are the major institutional investors of ESSA Pharma?: ESSA Pharma's top institutional investors include:
Bellevue Group AG — 17.76%
RTW Investments LP — 7.35%
PFM Health Sciences LP — 6.18%
Parkman Healthcare Partners LLC — 0.78%
Learn More about top institutional investors of ESSA Pharma stock.
Which institutional investors are selling ESSA Pharma stock?: In the last quarter, EPIX stock was sold by these institutional investors:
PFM Health Sciences LP
Bellevue Group AG
During the last year, company insiders that have sold ESSA Pharma company stock include:
Franklin M Berger (Director)
David Ross Parkinson (CEO)
Learn More investors selling ESSA Pharma stock.
Which institutional investors are buying ESSA Pharma stock?: In the last quarter, EPIX stock was bought by institutional investors including:
RTW Investments LP
Parkman Healthcare Partners LLC
In the last year, these company insiders have bought ESSA Pharma stock:
Franklin M Berger (Director)
David Ross Parkinson (CEO)
Learn More investors buying ESSA Pharma stock.